Where innovation meets wound care and hemostasis.
Where innovation meets wound care and hemostasis.
HEALTH & CARE Domain
KitOzyme is developing a new platform dedicated to wound care and hemostatic applications.
We are actively seeking partners to collaborate on the development of innovative solutions in this field. We are bringing more than 25 years of fungal biopolymer expertise into hemostasis and wound management, with a platform combining fungal chitosan, chitin-glucan and functionalized chitosan derivatives.
From ENT and mucosal applications to external hemostasis and wound care, we partner with medical device companies to turn clinical needs into differentiated solutions. Together, we define the right performance profile for each application and carry it through design characterisation and development, all the way to scalable manufacturing.
Developing the next generation of hemostatic or wound-care solutions?
For more than 25 years, KitOzyme has pioneered the development and industrial production of fungal chitosan and chitin-glucan ingredients.
Our expertise extends beyond manufacturing. We help partners select and integrate the most relevant molecular profile according to their formulation, application and targeted performance.
About KitOzymeWhat makes us different ?
Patent-backed technology. Supported by KitOzyme IP portfolio.
Pioneer and leader in fungal biopolymers
Belgian manufacturing expertise
EFSA health claim for fungal chitosan
FDA GRAS status
Novel Food authorization in Europe
ISO 13485 and HACCP certified manufacturing
Application and formulation guidance
Scientific and regulatory support from initial screening to industrial scale-up
Vegan, allergen-free, halal & kosher compatible
